University of California, Davis
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Davis sits in the top decile of US sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count).
University of California, Davis: 657 sponsored US clinical trials, 123 recruiting.
University of California, Davis sponsors 657 registered US clinical trials on ClinicalTrials.gov, 123 of them currently recruiting, and 435 completed. 38 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 12 trials.
Top-decile sponsor footprint
University of California, Davis ranks in the top decile of sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
435 of 483 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
657 total, page 2 of 14
Effects of Goji vs. Fiber on Macular Degeneration
NCT06237127
Pinch Grafting Versus Second Intention Wound Healing for Mohs Micrographic Surgery Defects on the Scalp
NCT06287866
Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
NCT06389123
Sparking Gut Bacteria Production of Bioactive Xenolipids in Situ
NCT06313606
Examining the Effectiveness of the Early Start Denver Model in Community Programs Serving Young Autism
NCT06005285
Single-tracer Multiparametric PET Imaging
NCT06014515
Fetal Endoscopic Tracheal Occlusion for CDH (CDH)
NCT05421676
Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6
NCT06228482
Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events
NCT06114615
Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma
NCT06211335
PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer
NCT06173349
Developing a Nutritional Supplement to Increase Collagen Synthesis in People
NCT06138106
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
NCT06173362
Biomarker-estimated Flavanol Intake in Davis (FID)
NCT06086145
Feasibility and Colorectal Benefits of Pulses Supplementation
NCT06032104
Aesthetic Outcome of Tie-over Bolster Application in Surgical Wounds
NCT05758168
Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)
NCT06101290
LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE)
NCT06103682
Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)
NCT06103669
Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
NCT06101277
Investigation of Locus Coeruleus Function in Sustained Attention
NCT06041048
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
NCT04984226
Somatic Dysfunction in Patients With Acute Cerebrovascular Disease
NCT06605014
The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation
NCT05967741
The Immune Effects of Fermented Wheat Germ Nutritional Supplementation in Patients With Advanced Solid Tumor Cancers Being Treated With Standard of Care Checkpoint Inhibitors
NCT05967533
Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)
NCT05489965
IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer
NCT05843448
A Research Study of Abdominal Ultrasound (FAST) in Children With Blunt Torso Trauma
NCT05910567
Fruit and Vegetable Biomarker Discovery
NCT05621863
Sacramento Clinical High Risk for Psychosis Stepped-Care Program
NCT06640803
Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education
NCT05761782
Physician Modified Endograft For Complex Aortic Aneurysm Repair
NCT05339061
Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery
NCT05886218
Enhancing Lung Cancer Screening Through Human-Centered Intervention
NCT06351085
Dual Frequency Stimulation in Parkinson's Disease
NCT04650932
Effects of Daily Beef Intake, as a Component of a Heart-Healthy Diet on Cellular Zinc
NCT05236374
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
NCT04428658
Fluorine-18-AlphaVBeta6-Binding Peptide Positron Emission Tomography in Metastatic Non-Small Cell Lung Cancer
NCT05452005
Chardonnay Marc and Vascular Response
NCT05545865
Dietary Intervention to Improve Kidney Transplant Outcomes
NCT05449496
The Effects of Dietary Supplementation on Serum Protein Glycosylation
NCT05040204
Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery
NCT05321134
Immunomodulatory Effects of Fasting in Healthy Adults
NCT05104502
Fidgeting and Attentional and Emotional Regulation in ADHD
NCT04526600
Senicapoc in Alzheimer's Disease
NCT04804241
Fluoroscopic Versus Ultrasound Guidance for Cooled Radiofrequency Ablation of Geniculate Nerves in Knee Osteoarthritis: A Randomized Control Trial
NCT04472702
Intra-sheath vs Extra-sheath Injection for De Quervain's Tenosynovitis
NCT04895956
The Influence of Honey-flavored Yogurt on Low-grade Inflammation and Gut Health in Middle to Older Aged Women.
NCT04248127
Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients
NCT05060991
Oxybutynin for Post-surgical Bladder Pain and Urgency
NCT03952299
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 43 |
| Phase 3 | 10 |
| Phase 4 | 28 |
Therapeutic Areas
What is open in the University of California, Davis pipeline
123 recruiting of 657 indexed (19% open); 435 completed (66%).
Phase mix: 38 late (III/IV) vs 129 early (I/II) (early-phase heavy).
Top condition: Healthy (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Davis: open-pipeline peers nationwide
Peers matched on 657 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 657 trials (± recruiting share)
- Vanderbilt University Medical Center · 677 trials · 19% recruiting
- University of Rochester · 636 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
- Insulet Corporation · 19% recruiting · 16 trials
- Medical University of South Carolina · 19% recruiting · 755 trials
Related
What to do with this University of California, Davis page
657 registered trials is a research-attention snapshot, not an endorsement of University of California, Davis or any single study.
- 123 of University of California, Davis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of California, Davis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of California, Davis pipeline card: 657 registered trials from official public datasets.Report a data error.